Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection (PIP-SBT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01760109 |
|
Recruitment Status :
Completed
First Posted : January 3, 2013
Last Update Posted : July 8, 2019
|
Sponsor:
Xiangbei Welman Pharmaceutical Co., Ltd
Information provided by (Responsible Party):
Xiangbei Welman Pharmaceutical Co., Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 2016 |
| Actual Study Completion Date : | June 2016 |